Hepatocellular Carcinoma and Sorafenib: How Can We Improve on the Current Standard of Care in Advanced Disease?

Advanced Research in Gastroenterology & Hepatology
doi 10.19080/argh.2017.03.555625
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Juniper Publishers

Related search

Can We Use Sorafenib Targeted Therapy for Advanced Hepatocellular Carcinoma (HCC) Child Pugh B

HPB
HepatologyGastroenterology
2016English

Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future

Clinical Liver Disease
Hepatology
2019English

Long Duration of Stable Disease May Improve Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Acta Hepatologica Japonica
Hepatology
2012English

Subtyping, Phenotyping or Endotyping Rosacea: How Can We Improve Disease Understanding and Patient Care?

British Journal of Dermatology
DermatologyMedicine
2018English

Pain Relief in Labour: How Can We Improve Intrapartum Care?

Open Journal of Obstetrics and Gynecology
2016English

Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis

Journal of Hepatology
Hepatology
2019English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Sorafenib for Advanced Hepatocellular Carcinoma (HCC): Impact of Rationing in the United Kingdom.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy